Jun S. Wei

13.4k total citations · 1 hit paper
92 papers, 5.4k citations indexed

About

Jun S. Wei is a scholar working on Molecular Biology, Neurology and Cancer Research. According to data from OpenAlex, Jun S. Wei has authored 92 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 31 papers in Neurology and 31 papers in Cancer Research. Recurrent topics in Jun S. Wei's work include Neuroblastoma Research and Treatments (26 papers), Sarcoma Diagnosis and Treatment (11 papers) and Cancer, Hypoxia, and Metabolism (11 papers). Jun S. Wei is often cited by papers focused on Neuroblastoma Research and Treatments (26 papers), Sarcoma Diagnosis and Treatment (11 papers) and Cancer, Hypoxia, and Metabolism (11 papers). Jun S. Wei collaborates with scholars based in United States, China and Germany. Jun S. Wei's co-authors include Javed Khan, Frank Westermann, Manfred Schwab, Frank Berthold, Marc Ladanyi, Cristina R. Antonescu, Paul S. Meltzer, Markus Ringnér, Carsten Peterson and Lao H. Saal and has published in prestigious journals such as Nature Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Jun S. Wei

90 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks

2001 1.9k citations Javed Khan, Jun S. Wei et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jun S. Wei United States	34	3.4k	1.1k	887	730	618	92	5.4k
Frank Westermann Germany	43	6.3k 1.9×	3.2k 2.8×	2.4k 2.7×	1.4k 1.9×	428 0.7×	118	8.9k
Sorin Drăghici United States	47	6.6k 2.0×	1.4k 1.3×	161 0.2×	475 0.7×	706 1.1×	171	10.7k
Michael Reich United States	22	6.5k 1.9×	1.3k 1.1×	160 0.2×	1.2k 1.6×	654 1.1×	42	9.6k
Holly K. Dressman United States	39	4.5k 1.3×	1.9k 1.7×	131 0.1×	1.4k 1.9×	716 1.2×	75	6.7k
Andrew P. Weng Canada	32	5.7k 1.7×	1.2k 1.0×	328 0.4×	1.8k 2.5×	320 0.5×	100	9.0k
Thomas D. Wu United States	33	3.7k 1.1×	1.6k 1.5×	171 0.2×	1.1k 1.6×	491 0.8×	57	7.0k
Yidong Chen United States	46	5.4k 1.6×	1.9k 1.7×	110 0.1×	961 1.3×	583 0.9×	215	7.3k
Jane Staunton United States	12	3.9k 1.2×	676 0.6×	88 0.1×	843 1.2×	513 0.8×	16	6.0k
Jan Komorowski Poland	38	4.2k 1.3×	1.3k 1.1×	125 0.1×	566 0.8×	240 0.4×	224	6.9k
Wing‐Kin Sung Singapore	45	6.5k 1.9×	1.1k 1.0×	130 0.1×	487 0.7×	335 0.5×	211	8.6k

Countries citing papers authored by Jun S. Wei

Since Specialization

Citations

This map shows the geographic impact of Jun S. Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun S. Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun S. Wei more than expected).

Fields of papers citing papers by Jun S. Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun S. Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun S. Wei. The network helps show where Jun S. Wei may publish in the future.

Co-authorship network of co-authors of Jun S. Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Jun S. Wei. A scholar is included among the top collaborators of Jun S. Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun S. Wei. Jun S. Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Yanwei, et al.. (2025). Investigation of the association between circulating inflammatory proteins and encephalitis risk in Europeans by two-sample Mendelian randomization analysis. Frontiers in Neurology. 15. 1450735–1450735.

Wu, Yiqun, Zhongshi Wang, Ying Zhu, et al.. (2024). Microenvironment Responsive Hydrogel Exerting Inhibition of Cascade Immune Activation and Elimination of Synovial Fibroblasts for Rheumatoid Arthritis Therapy. Journal of Controlled Release. 370. 747–762. 24 indexed citations

Wei, Jun S., et al.. (2024). A novel treatment modality for rheumatoid arthritis: Inflammation-targeted multifunctional metal-organic frameworks with synergistic phototherapy and chemotherapy. Colloids and Surfaces B Biointerfaces. 239. 113952–113952. 12 indexed citations

Xiao, Xin, Min Li, Zhi Ye, et al.. (2023). FUS gene mutation in amyotrophic lateral sclerosis: a new case report and systematic review. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 25(1-2). 1–15. 8 indexed citations

Song, Young, Purushottam B. Tiwari, Hsien-Chao Chou, et al.. (2023). Piperacetazine Directly Binds to the PAX3::FOXO1 Fusion Protein and Inhibits Its Transcriptional Activity. Cancer Research Communications. 3(10). 2030–2043. 3 indexed citations

Wei, Jun S., et al.. (2021). Requirement of transcription factor NME2 for the maintenance of the stemness of gastric cancer stem-like cells. Cell Death and Disease. 12(10). 924–924. 14 indexed citations

López, Gonzalo, Karina L. Conkrite, Komal S. Rathi, et al.. (2020). Somatic structural variation targets neurodevelopmental genes and identifies SHANK2 as a tumor suppressor in neuroblastoma. Genome Research. 30(9). 1228–1242. 14 indexed citations

Yang, Richard K., Igor B. Kuznetsov, Erik A. Ranheim, et al.. (2020). Outcome-Related Signatures Identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated after Starting Hu14.18-IL2. Clinical Cancer Research. 26(13). 3296–3306. 17 indexed citations

Wei, Jun S., Igor B. Kuznetsov, Shile Zhang, et al.. (2018). Clinically Relevant Cytotoxic Immune Cell Signatures and Clonal Expansion of T-Cell Receptors in High-Risk MYCN -Not-Amplified Human Neuroblastoma. Clinical Cancer Research. 24(22). 5673–5684. 76 indexed citations

10.

Wei, Jun S., et al.. (2017). A potential anticancer ability of 1,2-di(quinazolin-4-yl)diselane against gastric cancer cells through ROS signaling pathway. Medicinal Chemistry Research. 26(4). 841–848. 4 indexed citations

11.

Wei, Jun S., et al.. (2017). MicroRNA-31 Function as a Suppressor Was Regulated by Epigenetic Mechanisms in Gastric Cancer. BioMed Research International. 2017. 1–11. 22 indexed citations

12.

Wei, Jun S., Jennifer Li, Shuguang Zhu, et al.. (2017). MicroRNA-205 promotes cell invasion by repressing TCF21 in human ovarian cancer. Journal of Ovarian Research. 10(1). 33–33. 49 indexed citations

13.

Russell, Mike R., Derek A. Oldridge, Juan R. Alvarez‐Dominguez, et al.. (2015). CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus. Cancer Research. 75(15). 3155–3166. 120 indexed citations

14.

Xu, Zimu, Jun S. Wei, Jie Shen, et al.. (2015). Genetic effects of an air discharge plasma on Staphylococcus aureus at the gene transcription level. Applied Physics Letters. 106(21). 30 indexed citations

15.

Zhang, Congjun, et al.. (2013). Gap Functions and Algorithms for Variational Inequality Problems. Journal of Applied Mathematics. 2013. 1–7. 1 indexed citations

16.

Wang, Chunxi, Zhihui Liu, Zhijie Li, et al.. (2011). EZH2 Mediates Epigenetic Silencing of Neuroblastoma Suppressor Genes CASZ1 , CLU , RUNX3 , and NGFR. Cancer Research. 72(1). 315–324. 140 indexed citations

17.

Wei, Jun S., Peter A. Johansson, Qingrong Chen, et al.. (2009). microRNA Profiling Identifies Cancer-Specific and Prognostic Signatures in Pediatric Malignancies. Clinical Cancer Research. 15(17). 5560–5568. 44 indexed citations

18.

Chen, Qingrong, Christopher D. Benjamin, Adam Cheuk, et al.. (2009). Screening a panel of drugs with diverse mechanisms of action yields potential therapeutic agents against neuroblastoma. Cancer Biology & Therapy. 8(24). 2386–2395. 21 indexed citations

19.

Westermann, Frank, Kai-Oliver Henrich, Jun S. Wei, et al.. (2007). High Skp2 Expression Characterizes High-Risk Neuroblastomas Independent of MYCN Status. Clinical Cancer Research. 13(16). 4695–4703. 39 indexed citations

20.

Whiteford, Craig C., Sven Bilke, Braden T. Greer, et al.. (2007). Credentialing Preclinical Pediatric Xenograft Models Using Gene Expression and Tissue Microarray Analysis. Cancer Research. 67(1). 32–40. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact